Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

por Albertsson-Lindblad, Alexandra, Freiburghaus, Catja, Jerkeman, Mats, Ek, Sara
Publicado 2019

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up

por Hagström, Hannes, Andreasson, Anna, Carlsson, Axel C., Jerkeman, Mats, Carlsten, Mattias
Publicado 2018

Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy

por Engleson, Jens, Soller, Maria, Panagopoulos, Ioannis, Dahlén, Anna, Dictor, Michael, Jerkeman, Mats
Publicado 2006

Expanded clinical and experimental use of SOX11 - using a monoclonal antibody

por Nordström, Lena, Andréasson, Ulrika, Jerkeman, Mats, Dictor, Michael, Borrebaeck, Carl, Ek, Sara
Publicado 2012

Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission

por Ekberg, Sara, Crowther, Michael, Harrysson, Sara, Jerkeman, Mats, E. Smedby, Karin, Eloranta, Sandra
Publicado 2022

HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis

por Mekuria, Selamawit F., Timmermans, Sydney, Borgfeldt, Christer, Jerkeman, Mats, Johansson, Pia, Linde, Ditte Søndergaard
Publicado 2023

S227: INITIAL SAFETY DATA FROM THE PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA, COMPARING R-POLA-MINI-CHP AND R-MINI-CHOP

por Jerkeman, Mats, Leppä, Sirpa, Hamfjord, Julian, Brown, Peter, Ekberg, Sara, José María Ferreri, Andrés
Publicado 2023

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation

por Ekberg, Sara, Smedby, Karin E., Albertsson-Lindblad, Alexandra, Jerkeman, Mats, Weibull, Caroline E., Glimelius, Ingrid
Publicado 2022

Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer

por Olofsson, Sven-Erik, Nodin, Björn, Gaber, Alexander, Eberhard, Jakob, Uhlén, Mathias, Jirström, Karin, Jerkeman, Mats
Publicado 2015

Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo

por Damm, Jesper Kofoed, Gordon, Sandra, Ehinger, Mats, Jerkeman, Mats, Gullberg, Urban, Hultquist, Anne, Drott, Kristina
Publicado 2015

Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

por Lokhande, Lavanya, Kuci Emruli, Venera, Kolstad, Arne, Hutchings, Martin, Räty, Riikka, Jerkeman, Mats, Ek, Sara
Publicado 2020

Survival in mantle cell lymphoma after frontline treatment with R-bendamustine, R-CHOP and the Nordic MCL2 regimen – a real world study on patients diagnosed in Sweden 2007-2017

por Albertsson-Lindblad, Alexandra, Palsdottir, Thorgerdur, Smedby, Karin E., Weibull, Caroline E., Glimelius, Ingrid, Jerkeman, Mats
Publicado 2021

SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies

por Gustavsson, Elin, Sernbo, Sandra, Andersson, Elin, Brennan, Donal J, Dictor, Michael, Jerkeman, Mats, Borrebaeck, Carl AK, Ek, Sara
Publicado 2010

Clinical Characteristics and Histopathological Patterns of Hodgkin Lymphoma and Treatment Outcomes at a Tertiary Cancer Center in Ethiopia

por Adam, Makka, Bekueretsion, Yonas, Abubeker, Abdulaziz, Tadesse, Fisihatsion, Kwiecinska, Anna, Howe, Rawleigh, Petros, Beyene, Jerkeman, Mats, Gebremedhin, Amha
Publicado 2021

Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients

por Mead, Monica, Cederleuf, Henrik, Björklund, Maja, Wang, Xiaoyan, Relander, Thomas, Jerkeman, Mats, Gaut, Daria, Larson, Sarah, Ellin, Fredrik
Publicado 2022

Incidence of relapsed/refractory diffuse large B-cell lymphoma (DLBCL) including CNS relapse in a population-based cohort of 4243 patients in Sweden

por Harrysson, Sara, Eloranta, Sandra, Ekberg, Sara, Enblad, Gunilla, Jerkeman, Mats, Wahlin, Bjorn E., Andersson, Per-Ola, Smedby, Karin E.
Publicado 2021

EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 Pandemic

por Dreyling, Martin, Aurer, Igor, Federico, Massimo, Jerkeman, Mats, Kersten, Marie Jose, Linton, Kim, Mey, Ulrich, Tilly, Herve, Buske, Christian
Publicado 2021

Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

por Freiburghaus, Catja, Emruli, Venera Kuci, Johansson, Angelica, Eskelund, Christian Winther, Grønbæk, Kirsten, Olsson, Roger, Ek, Fredrik, Jerkeman, Mats, Ek, Sara
Publicado 2018

Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐IPI, IPI, and NCCN‐IPI

por Biccler, Jorne, Eloranta, Sandra, de Nully Brown, Peter, Frederiksen, Henrik, Jerkeman, Mats, Smedby, Karin E., Bøgsted, Martin, El‐Galaly, Tarec C.
Publicado 2017

Tackling Mantle Cell Lymphoma in Europe

por Horgan, Denis, Walewski, Jan, Aurer, Igor, Visco, Carlo, Giné, Eva, Fetica, Bogdan, Jerkeman, Mats, Kozaric, Marta, da Silva, Maria Gomes, Dreyling, Martin
Publicado 2022